MARK ROMOFF: Open Payments
NPI 1578543179 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 11 payments from 7 companies in 2025. Trend: 2023 $608 · 2024 $498 · 2025 $277
Food & beverage: $239Education: $38
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $113 |
| Amgen Inc. | 2 | $51 |
| PFIZER INC. | 1 | $27 |
| Novo Nordisk Inc | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: JARDIANCE, EVENITY, NURTEC ODT, Ozempic, LEQVIO, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
